Literature DB >> 12149063

Ocular toxoplasmosis: a 50th anniversary tribute to the contributions of Helenor Campbell Wilder Foerster.

Gary N Holland1, Kevan G Lewis, G Richard O'Connor.   

Abstract

In 1952, Helenor Campbell Wilder (later Helenor Campbell Wilder Foerster) confirmed the growing suspicion that Toxoplasma gondii was a cause of uveitis in otherwise healthy adults by identifying the presence of parasites in eyes enucleated because of severe intraocular inflammation. Ocular toxoplasmosis was previously known to occur only in newborns with congenital T gondii infection. Her report ushered in a new era in the field of uveitis in which toxoplasmosis, rather than tuberculosis, was confirmed to be the most common cause of retinochoroiditis. Fifty years later, issues raised in her landmark publication are still being investigated.

Entities:  

Mesh:

Year:  2002        PMID: 12149063     DOI: 10.1001/archopht.120.8.1081

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

Review 1.  Toxoplasmosis: A history of clinical observations.

Authors:  Louis M Weiss; Jitender P Dubey
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

2.  Helenor Campbell Wilder Foerster.

Authors:  Rolika Bansal; Bruce E Spivey; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

3.  Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.

Authors:  Ana Luisa Quintella do Couto Aleixo; André Luiz Land Curi; Eliezer Israel Benchimol; Maria Regina Reis Amendoeira
Journal:  PLoS Negl Trop Dis       Date:  2016-05-02

4.  [Atypical ocular toxoplasmosis in a Congolese woman of 72 years: report of a case].

Authors:  Yogolelo Asani Bienvenu; Musau Nkola Angel; Kasamba Ilunga Eric; Kapalu Mwangala Socrate; Mbuyi Musanzayi Sebastien; Cilundika Mulenga Philippe; Kabamba Ngombe Leon; Iye Ombamba Kayimba Bruno; Chenge Borasisi Gaby
Journal:  Pan Afr Med J       Date:  2015-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.